Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis

NCT05016284 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Lack of funding

Conditions

Atopic Dermatitis

Interventions

OTHER: JW-100
DRUG: Eucrisa

Sponsor

Applied Biology, Inc.

Collaborators

[object Object]